Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia - Trial NCT06364228
Access comprehensive clinical trial information for NCT06364228 through Pure Global AI's free database. This Phase 2 trial is sponsored by University of Nebraska and is currently Not yet recruiting. The study focuses on Stress. Target enrollment is 32 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Nebraska
Timeline & Enrollment
Phase 2
Jul 01, 2024
Apr 01, 2026
Primary Outcome
Participants' chronic stress levels in the past thirty days.
Summary
The proposed study is a double-blind, randomized, placebo-controlled study of intranasal
 oxytocin (OXT) to determine its efficacy in improving quality of life and reducing stress in
 caregivers to persons with dementia. Planned enrollment is 32 subjects over 2 years.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06364228
Non-Device Trial